Loading…

Demonstrating Measurement Equivalence of the Electronic and Paper Formats of the Urticaria Patient Daily Diary in Patients with Chronic Idiopathic Urticaria

Background The Urticaria Patient Daily Diary (UPDD), originally developed on paper, is a measure of key symptoms of chronic idiopathic urticaria (CIU). The development of the electronic version (eUPDD) involved moderate modifications to the appearance of the paper version. Objective This study asses...

Full description

Saved in:
Bibliographic Details
Published in:The patient : patient-centered outcomes research 2013-09, Vol.6 (3), p.225-231
Main Authors: Flood, Emuella M., Zazzali, James L., Devlen, Jennifer
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The Urticaria Patient Daily Diary (UPDD), originally developed on paper, is a measure of key symptoms of chronic idiopathic urticaria (CIU). The development of the electronic version (eUPDD) involved moderate modifications to the appearance of the paper version. Objective This study assessed the measurement equivalence of the electronic and paper versions of the UPDD in a sample of patients with CIU. Methods This was a cross-over study of patients with moderate–severe CIU refractory to H1 antihistamines. Patients were randomized to either the eUPDD followed by the paper UPDD or vice versa. The UPDD includes morning and evening questions; both sets were administered together in this study. An hour-long filler task was given between paper and electronic administrations. Patients with stable symptoms between the two assessments were included in the analyses. Cohen’s kappa coefficients and intraclass correlation coefficients (ICC) were computed as applicable to assess equivalence. Results A total of 91 patients participated (mean age 43 years, 79.1 % female). Symptoms were stable between assessments for 67–74 (74–81 %) patients (varied by symptom). Kappa coefficients ranged from 0.82 to 1.00 for the individual UPDD items. For the Urticaria Activity Score (the sum of the ‘itch severity’ and ‘number of hives’ item scores) the ICC was 0.90 for the morning (Wilcoxon p  = 0.331) and 0.95 for the evening (Wilcoxon p  = 0.836). Conclusions All test–retest statistics in this study were well above the accepted threshold, indicating excellent agreement between the two administration methods. Findings support the measurement equivalence of the electronic and paper versions of the UPDD to measure CIU symptoms.
ISSN:1178-1653
1178-1661
DOI:10.1007/s40271-013-0021-4